MK

Mary E. Klotman

Director, Amgen

Mary E. Klotman is a director at Amgen. Their most recent Section 16 filing is from May 2026.

Known for
director at Amgen

Sign up

Get your curated digest

After email confirmation, you will receive a daily digest of the most relevant news that matter to your portfolio